Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-04-03
2000-01-25
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 514765, 530324, 530325, 530326, 530327, 530317, A61K 3812, A61K 3816
Patent
active
060178795
ABSTRACT:
The present invention is directed to agonists of neuropeptide Y (NPY) or PYY that are formed by combining these peptides or a portion of these peptides with a template that promotes biologically active folds. Typically, templates consist of cyclized peptides containing one or more naphthyl ring structures. The agonists may be used in the treatment of diseases and conditions known to be responsive to NPY or PYY and, particularly in the treatment of asthma, rhinitis, and bronchitis.
REFERENCES:
patent: 5696093 (1997-12-01), Tseng et al.
Baraniuk, et al., "Neuropeptide Y (NPY) in Human Nasal Mucosa," Am. J. Respir. Cell. Mol. Biol. 3:165-173 (1990).
Baraniuk, et al., "Neuropeptide Y is a Vasoconstrictor in Human Nasal Mucosa," J. Applied Physiol. 73:1867-1872 (1992).
Beck-Sickinger, et al., "Complete L-Alanine Scan of Neuropeptide Y Reveals Ligands Binding to Y.sub.1 and Y.sub.2 Receptors With Distinguished Conformations," Eur. J. Biochem. 225:947-958 (1994).
Dumy, et al., "A Convenient Synthesis of Cyclic Peptides as Regioselectively Addressable Functionalized Templates (RAFT)," Tetrahedron Letters 36:1255-1258 (1995).
Ekblad, et al., "Neuropeptide Y Co-exists and Co-operates With Noradrenaline in Perivascular Nerve Fibers," Regulatory Peptides 8:225-235 (1984).
Ernest, et al., "Three Novel Mimics for the Construction of Sterically Constrained Protein Turn Models," Tetrahedron Letters 31:4011-4014 (1990).
Ernest, et al., "Cyclic Templates With Incorporated Turn-Inducing Mimics," Helvetica Chimica Acta 76:1539-1563 (1993).
Futaki, et al., "Preparation of Peptide Thioesters Using Fmoc-Solid-Phase Peptide Synthesis and Its Application to the Construction of a Template-Assembled Synthetic Protein (TASP)," Tetrahedron Letters 38:6237-6240 (1997).
Grouzmann, et al., "A Specific Template-Assembled Peptidic Agonist for the Angiotensin II Receptor Subtype 2 (AT2) and Its Effect on Inferior Olivary Neurones," Eur. J. Biochem. 234:44-49 (1995).
Grouzmann, et al., "Characterization of a Selective Antagonist Neuropeptide Y at the Y2 Receptor," J. Biol. Chem. 272:7699-7706 (1997).
Grove, et al., "Template-Assembled Synthetic Proteins Designed to Adopt a Globular, Four-Helix Bundle Conformation Form Ionic Channels in Lipid Bilayers," J. Am. Chem. Soc. 115: 5919-5924 (1993).
LaCroix, et al., "Intranasal Administration of Neuropeptide Y in Man: Systemic Absorption and Functional Effects," Brit. J. Pharmacol. 118:2079-2084 (1996).
LaCroix, et al., "Attenuation of Allergen-Evoked Nasal Responses by Local Pretreatment With Exogenous Neuropeptide Y in Atopic Patients," J. Allergy Clin. Immunol. 98:611-616 (1996).
LaCroix, et al., "Post-Exercise Nasal Vasoconstriction and Hyporeactivity: Possible Involvement of Neuropeptide Y," Acta Otolaryngol (Stockh.)117:000-000 (1997).
Michel, "Receptor for Neuropeptide Y: Multiple Subtypes and Multiple Second Messengers," Trends in Pharmacol. Sci. 12:389-394 (1991).
Minth, et al., "Cloning, Characterization, and DNA Sequence of a Human cDNA Encoding Neuropeptide Tyrosine," Proc. Natl. Acad. Sci. USA 81:4577-4581 (1984).
Mutter, et al., "Artificial Folding Units of Assembly of Amphiphilic Secondary Structures on a Template," Helvetica Chimica Acta 71:835-847 (1988).
Mutter, "Nature's Rules and Chemist's Tools: A Way for Creating Novel Proteins," Trends in Biochem. Sci. 13:260-265 (1988).
Mutter, et al., "A Chemical Approach to Protein Design-Template-Assembled Synthetis Proteins (TASP)," Angewandte Chemie 28:535-676 (1989).
Mutter, et al., "Template-Assembled Synthetic Proteins With Four-Helix-Bundle Topology. Total Chemical Synthesis and Conformational Studies," J. Am. Chem. Soc. 114:1463-1470 (1992).
Mutter, et al., "Non-Native Architectures in Protein Design and Mimicry," CMLS, Cell. Mol. Life Sci. 53:851-863 (1997).
Nyanguile, et al., "Synthesis of Antiparallel 4.alpha.-Helix Bundle TASP by Chemoselective Ligation," Letters in Peptide Sci. 1:9-16 (1994).
Rist, et al., "Modified, Cyclic Dodecapeptide Analog of Neuropeptide Y is the Smallest Full Agonist at the Human Y.sub.2 Receptor," FEBS Letters 394:169-173 (1996).
Sahu, et al., "Neuropeptidergic Regulation of Feeding Behavior, Neuropeptide Y," Trends in Endocrinology & Metabolism 4:217-224 (1993).
Sila, et al., "Topological Templates as Tool in Molecular Recognition and Peptide Mimicry: Synthesis of a TASK Library," J. Mol. Recog. 8:29-34 (1995).
Stanley, et al., "Neuropeptide Y Injected in the Paraventricular Hypothalamus: A Powerful Stimulant of Feeding Behavior," Proc. Natl. Acad. Sci. USA 82:3940-2943 (1985).
Tuchscherer, et al., "Total Chemical Synthesis, Characterization, and Immunological Properties of an MHC Class I Model Using the TASP Concept for Protein de novo Design," Protein Science 1:1377-1386 (1992).
Tuchscherer, et al., "Designing Novel Proteins," Chemistry & Industry 4:597-601 (1997).
Wahlestedt, et al., "Neuropeptide Y-Related Peptides and Their Receptors-Are the Receptors Potential Therapeutic Drug Targets?," Ann. Rev. Pharmacol. Toxicol. 32:309-352 (1993).
Walker, et al., "The Role of Neuropeptide Y in Cardiovascular Regulation," Trends in Pharmacol. Sci. 12:111-115 (1991).
Ngo et al., `Computational Complexity, Potein Structure Prediction, and the Levinthal Paradox,` The Protein Folding Problem and Tertiary Structure Prediction. Ed. K. Merz and L. Le Grand. BirkHauser, Boston MA. pp. 491-495, 1994.
Rudinger, J. (1976). Peptide Hormones (ed. J.A. Parsons). University Park Press. Baltimore. pp. 1-7, 1976.
Grouzmann Eric
Lacroix Jean-Silvain
Mutter Manfred
B.M.R.A. Corporation B.V.
Gupta Anish
Sanzo Michael A.
Tsang Cecilia J.
LandOfFree
Template associated NPY Y2-receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Template associated NPY Y2-receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Template associated NPY Y2-receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2315962